“Global pharmaceutical companies are now using artificial intelligence (AI) to drive health and market outcomes, and maximise their returns on investment. As the Global Head of Digital Solutions at Novartis, David Verdura, said at Eyeforpharma earlier this year: ‘if a pharma company hasn’t realised they need to change into a technology company, they probably should.’ However, healthcare data is currently overwhelmingly complex, stored in silos, and difficult to apply across stakeholders. Life sciences companies are in a unique position to lead on data access – demonstrating how technology can drive patient outcomes beyond traditional clinical trials and observational studies.”
Did this report add value to you? We are currently developing our 2019 thought leadership series.
Please do let us know your feedback.